Opiate receptor binding properties of morphine-, dihydromorphine-, and codeine 6-O-sulfate ester congeners

Bioorganic and Medicinal Chemistry Letters

Volumn 16, Issue 16, 2006, Pages 4291-4295

  Crooks, Peter A ^a   Kottayil, Santosh G ^b   Al Ghananeem, Abeer M ^a   Byrn, Stephen R ^c   Allan Butterfield, D ^b  

^a University of Kentucky   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c PURDUE UNIVERSITY   (United States)

Author keywords

Morphine analogs; Opiate receptors; Sulfate conjugates

Indexed keywords

CODEINE; CODEINE 6 O SULFATE; DELTA OPIATE RECEPTOR; DIHYDROCODEINE; DIHYDROMORPHINE; DIHYDROMORPHINE 6 O SULFATE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR; METENKEPHALIN; MORPHINE; MORPHINE 3 O PROPIONYL 6 O SULFATE; MORPHINE 6 O SULFATE; MU OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; N METHYLMORPHINIUM IODIDE; OPIATE; OPIATE RECEPTOR; RECEPTOR SUBTYPE; SULFATE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG SELECTIVITY; DRUG SYNTHESIS; GUINEA PIG; NONHUMAN; RECEPTOR AFFINITY;

ANIMALS; CODEINE; DIHYDROMORPHINE; ESTERS; GUINEA PIGS; INHIBITORY CONCENTRATION 50; KINETICS; LIGANDS; MODELS, CHEMICAL; MORPHINE; PROTEIN BINDING; SULFATES;

EID: 33745713206     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.05.060     Document Type: Article

References (21)

1. Sjoegren P., and Zylicz Z. Pol. Med. Paliatywna 3 (2004) 101
2. Loetsch J., Skark C., Schmidt H., Rohrbacher M., Hofmann U., Schwab M., and Geisslinger G. Clin. Pharmacol. Ther. 79 (2006) 35
3. Paul D., Standifer K.M., Inturrisi C.E., and Pasternak G.W. J. Pharmacol. Exp. Ther. 251 (1989) 477
4. Shimomura K., Kamata O., Ueka S., Ida S., Oguri K., and Yoshimura H. Tohoku J. Exp. Med. 105 (1971) 45
5. Mori M., Oguri K., Yoshimura H., Shimomura K., Kamata O., and Ueka S. Life Sci. 11 (1972) 525
6. Watrous W.M., Fujimoto J.M., and Haarstad V.B. Pharmacologist 10 (1968) 173
7. Yeh S.Y., Chernov H.I., and Woods L.A. J. Pharm. Sci. 60 (1971) 469
8. Donnerer J., Cardinale J.C., Lisek C.A., Jardine I., and Spector S. Pharmacol. Exp. Ther. 242 (1987) 583
9. Nagano E., Yamada H., and Oguri K. Life Sciences 67 (2000) 2453
10. Brown C.E., Roerig S.C., Burger V.T., Cody R.B., and Fujimoto J.M. J. Pharm. Sci. 74 (1985) 821
11. Thompson C.M., Wojno H., Greiner E., May E.L., Rice K.C., and Selley D.E. J. Pharmacol. Exp. Ther. 308 (2004) 547
12. Oguri K., Yamada M.I., Shigezane J., Hirano T., and Yoshimura H. Life Sci. 41 (1987) 1457
13. Zuckerman A., Bolan E., de Paulis T., Schmidt D., Spector S., and Pasternak G.W. Brain Res. 842 (1999) 1
14. Houdi A.A., Kottayil S., Crooks P.A., and Butterfield D.A. Pharmacol., Biochem. Behav. 53 (1996) 665
15. Kottayil, S.; Butterfield, D. A.; Crooks, P. A. 202nd National Meeting of the American Chemical Society, 1991; MEDI 149.
16. Preechagoon D., Brereton I., Staatz C., and Prankerd R. Int. J. Pharm. 163 (1998) 177
17. Kottayil, S. G. Ph.D. Thesis, University of Kentucky, 1993.
18. 13 have been previously characterized in the literature. The characterization data for the following compounds: M3IBu6S, M3P6S, M3B6S, DM3A6S, DM3B6S, MM3A6S, and MM3B6S are reported in Ref. 21.
19. Fridrichsons J., Mackay M.F., and Mathieson A.M. Tetrahedron Lett. 24 (1968) 2887
20. Brock C.P., Kottayil S., Butterfield D.A., and Crooks P.A. Acta Crystallogr., Sect. C C52 (1996) 122
21. Crooks, P. A.; Houdi, A. A.; Kottayil, S. G.; Butterfield, D. A. U.S. Patent 6,403,602, 2002.